Psychiatric disorder
MONDO:0002025A disorder characterized by behavioral and/or psychological abnormalities, often accompanied by physical symptoms. The symptoms may cause clinically significant distress or impairment in social and occupational areas of functioning. Representative examples include anxiety disorders, cognitive disorders, mood disorders and schizophrenia.
Also known as: Psychiatric disease, Psychiatric disorder, disease of mental health, mental disorder, mental dysfunction, mental illness
12332 clinical trials for this condition and its sub-types, 488 tagged with Psychiatric disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Psychiatric disorder
-
Mental disorder 250 trials · 7,390 incl. sub-types
14 sub-types
- Anxiety disorder 2,034 trials · 3,121 incl. sub-types Sub-types →
- Mood disorder 184 trials · 2,673 incl. sub-types Sub-types →
- Developmental disorder of mental health 1 trial · 1,590 incl. sub-types Sub-types →
- Psychotic disorder 201 trials · 769 incl. sub-types Sub-types →
- Pain agnosia 146 trials
- Psychosexual disorder 4 trials · 47 incl. sub-types Sub-types →
- Adjustment disorder 34 trials
- Disruptive behavior disorder 34 trials
- Alcohol-induced mental disorder 0 trials · 24 incl. sub-types Sub-types →
- Drug-induced mental disorder 1 trial · 8 incl. sub-types Sub-types →
- Visual agnosia 0 trials · 2 incl. sub-types Sub-types →
- Akinetopsia 0 trials
- Cortical deafness 0 trials
- Tactile agnosia 0 trials
-
Cognitive disorder 444 trials · 3,177 incl. sub-types
6 sub-types
- Dementia 738 trials · 1,795 incl. sub-types Sub-types →
- Psychotic disorder 201 trials · 769 incl. sub-types Sub-types →
- Delirium 258 trials Sub-types →
- Subjective cognitive decline 115 trials
- Amnestic disorder 4 trials · 6 incl. sub-types Sub-types →
- Alexia 2 trials
-
Substance-related disorder 559 trials · 2,323 incl. sub-types
4 sub-types
- Substance dependence 15 trials · 1,294 incl. sub-types Sub-types →
- Substance abuse 198 trials · 892 incl. sub-types Sub-types →
- Alcohol-related disorders 34 trials · 626 incl. sub-types Sub-types →
- Substance withdrawal syndrome 30 trials · 59 incl. sub-types Sub-types →
-
Eating disorder 157 trials · 362 incl. sub-types
6 sub-types
- Anorexia nervosa 156 trials Sub-types →
- Binge eating disorder 85 trials
- Bulimia nervosa 64 trials
- Avoidant/restrictive food intake disorder 28 trials
- Rumination disorder 26 trials
- Pica disease 0 trials
-
Personality disorder 24 trials · 172 incl. sub-types
10 sub-types
- Borderline personality disorder 74 trials
- Obsessive-compulsive personality disorder 44 trials
- Schizotypal personality disorder 20 trials
- Antisocial personality disorder 12 trials
- Narcissistic personality disorder 2 trials
- Avoidant personality disorder 1 trial
- Dependent personality disorder 0 trials
- Histrionic personality disorder 0 trials
- Paranoid personality disorder 0 trials
- Schizoid personality disorder 0 trials
-
Somatoform disorder 47 trials · 127 incl. sub-types
6 sub-types
- Conversion disorder 48 trials
- Somatization disorder 21 trials
- Body dysmorphic disorder 19 trials · 20 incl. sub-types Sub-types →
- Hypochondriasis 12 trials
- Physiological malfunction arising from mental factor 2 trials
- Neurocirculatory asthenia 1 trial
-
Impulse control disorder 21 trials · 66 incl. sub-types
7 sub-types
- Pathological gambling 28 trials
- Trichotillomania 11 trials
- Intermittent explosive disorder 4 trials
- Primary polydipsia 2 trials Sub-types →
- Kluver-Bucy syndrome 0 trials
- Kleptomania 0 trials
- Pyromania 0 trials
-
Sexual disorder 3 trials · 66 incl. sub-types
4 sub-types
- Psychosexual disorder 4 trials · 47 incl. sub-types Sub-types →
- Premature ejaculation 17 trials
- Sexual sadism disorder 1 trial
- Sexual masochism disorder 0 trials
-
Enuresis 9 trials · 32 incl. sub-types
1 sub-type
- Nocturnal enuresis 29 trials Sub-types →
-
Dissociative disorder 16 trials · 19 incl. sub-types
3 sub-types
- Multiple personality disorder 6 trials
- Depersonalization disorder 1 trial
- Dissociative amnesia 0 trials
-
Catatonia 12 trials
1 sub-type
- Idiopathic catatonia 0 trials
-
Alice in Wonderland syndrome 0 trials
-
Body integrity dysphoria 0 trials
-
Factitious disorder 0 trials
1 sub-type
- Munchausen by proxy 0 trials
Most studied deeper sub-types
-
New drug aims to slow Alzheimer's in early stages
Disease control Stopped earlyThis study tests an experimental drug called GSK4527226 in 367 people with early Alzheimer's (mild memory problems or mild dementia). Participants receive either a low dose, high dose, or placebo through an IV. The goal is to see if the drug can slow down declines in memory and d…
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could a blood pressure drug combo tame panic attacks?
Disease control Stopped earlyThis phase 2 trial tests a new drug called HB-1, which combines two blood pressure medicines (telmisartan and verapamil), to see if it can reduce unexpected panic attacks in people with panic disorder. The study plans to enroll 240 adults aged 18 to 65 and compare HB-1 against pl…
Phase 2 • Sponsor: HB BioTech, LLC • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a new daily pill offer safer Long-Term schizophrenia control?
Disease control Stopped earlyThis trial is testing whether emraclidine, an experimental oral medication taken once daily for a year, is safe and tolerable for adults with schizophrenia. Participants who completed earlier studies of emraclidine may join, and researchers will monitor side effects, vital signs,…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Simple work advice may cut sick leave days, trial suggests
Disease control Stopped earlyThis trial tests whether a short vocational advice program helps people on sick leave return to work sooner. Adults who have been off work for at least two weeks due to health issues receive support from a trained worker to identify barriers and plan their return. The study compa…
Sponsor: Keele University • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Alzheimer's drug ALZ-801 tested Long-Term in High-Risk group
Disease control Stopped earlyThis study looked at the long-term safety and effects of ALZ-801, a tablet taken twice daily, in 163 people with early Alzheimer's disease who have the APOE4/4 gene. Participants had already completed a previous phase 3 study. The goal was to see if the drug could slow cognitive …
Phase 3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Alzheimer's drug trial halted early: what happened?
Disease control Stopped earlyThis early-stage study tested a new drug, ADEL-Y01, in healthy volunteers and people with mild Alzheimer's or mild cognitive impairment. The goal was to check safety and how the drug moves through the body. The trial was stopped early, so results are limited.
Phase 1 • Sponsor: Alzheimer's Disease Expert Lab (ADEL), Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Alzheimer's drug extension trial halted early — what we know
Disease control Stopped earlyThis study gave Alzheimer's patients who had already completed earlier XPro1595 trials an extra 55 to 74 weeks of the drug to check long-term safety and effects on memory and brain health. Only 11 people took part, and the trial was terminated early, so the findings are limited. …
Phase 2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Mental health sessions may boost vaccine uptake in latinx communities
Prevention Stopped earlyThis study tested whether adding vaccine discussions to routine behavioral health visits could reduce hesitancy and increase COVID-19 and flu shots among Latinx adults with mental illness. Clinicians used motivational interviewing and could offer a warm handoff to a nurse for vac…
Sponsor: Boston College • Aim: Prevention
Last updated Jun 26, 2026 17:00 UTC
-
Experimental drug MIJ821 aims to quickly ease depression and suicidal urges
Symptom relief Stopped earlyThis study tested an experimental drug called MIJ821, given as an IV infusion, to see if it could quickly reduce depression symptoms in people with major depressive disorder who also have active suicidal thoughts. About 199 adults aged 18 to 65 took part, receiving either MIJ821 …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Tiny study compares trazodone and quetiapine for ICU delirium – but was cut short
Symptom relief Stopped earlyThis pilot study aimed to compare trazodone and quetiapine for treating delirium in ICU patients. It enrolled only 10 adults in the surgical ICU who had delirium with symptoms like agitation or hallucinations. The study was terminated early, so the results are very limited and ca…
Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
HIV-Positive Men's mental health study shuts down after just one participant
Symptom relief Stopped earlyThis study aimed to see if acceptance and commitment therapy (ACT), a type of talk therapy, could help HIV-positive men with mental health issues like stress and anxiety. Only one person enrolled before the study was stopped early. Because of this, no meaningful results were obta…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Can a life map help mental health providers see the full picture?
Knowledge-focused Stopped earlyResearchers are testing a web-based tool called the Tulsa Life Chart that helps patients visually map their life history, from mood and relationships to medical conditions and substance exposure. The study includes people seeking mental health treatment and their healthcare provi…
Sponsor: Laureate Institute for Brain Research, Inc. • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Zapping the brain to unravel OCD in kids
Knowledge-focused Stopped earlyThis study looked at how a gentle brain stimulation technique called tDCS affects thinking and behavior in children aged 10-17 with obsessive-compulsive disorder (OCD). The goal was to understand brain processes linked to OCD, not to treat the condition. Only 6 participants were …
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Mental health study aims to uncover Long-Term heart risks
Knowledge-focused Stopped earlyThis study followed 167 adults with mental health issues like anxiety, depression, or sleep problems who visited their primary care doctor. Researchers used health conversations and a blood test to track lifestyle changes and heart disease risks over up to 20 years. The goal was …
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Mindfulness for caregivers: a Stress-Reduction experiment that ended early
Knowledge-focused Stopped earlyThis study aimed to see if a mindfulness-based stress reduction program could lower stress and inflammation in people caring for someone with a severe psychiatric disorder. Researchers planned to compare a group taking mindfulness classes with a group receiving standard care, mea…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC